vimarsana.com

Ontario Clinical Oncology Group News Today : Breaking News, Live Updates & Top Stories | Vimarsana

FDA Grants IceCure Medical s Appeal: Reopens De Novo Classification Request for Marketing Authorization of ProSense for Early-Stage Breast Cancer

IceCure Medical Ltd. has announced that the Food and Drug Administration (FDA) has granted its appeal and reopened its De Novo Classification Request for Marketing Authorization of its ProSense cryoablation technology for early-stage breast cancer.

Patients with low-risk breast cancer may not require radiotherapy: Study

Patients with low-risk breast cancer may not require radiotherapy: Study
bignewsnetwork.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bignewsnetwork.com Daily Mail and Mail on Sunday newspapers.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.